Sarah Bennett
Smallpox is a deadly virus that has killed millions of people worldwide throughout history. The development of the smallpox vaccine in the late 1700s by English physician Edward Jenner is considered one of humanity's greatest achievements. The vaccine was created using a poxvirus that infects cows (cowpox), which provides immunity to smallpox in humans. While the vaccine has had side effects, from mild to severe, the mortality rate associated with its careful selection and administration was close to zero. The last known case of naturally acquired smallpox occurred in 1977, and the World Health Organization (WHO) declared the disease eradicated in 1980. Today, due to the absence of smallpox cases, the risks of the vaccine are considered to outweigh the benefits for the general population.
| Characteristics | Values |
|---|---|
| Did everyone who took the smallpox vaccine die? | No |
| Who discovered the smallpox vaccine? | Dr. Edward Jenner |
| When was the smallpox vaccine discovered? | Late 1700s (1796) |
| Where was the smallpox vaccine first introduced? | Trinity, Newfoundland, in 1798 |
| How was the smallpox vaccine discovered? | Dr. Jenner noticed that milkmaids exposed to cowpox were immune to smallpox and tested his hypothesis by inoculating a boy with cowpox pus and then challenging him with smallpox. |
| What are the side effects of the smallpox vaccine? | Mild and self-limited to severe and life-threatening. One-third of first-time vaccinees develop significant side effects. Rare side effects include postvaccinal encephalitis and myopericarditis. |
| When did smallpox eradication efforts begin? | 1959 |
| When was smallpox eradicated? | 1970s-1980 |
| Who was the last person to die of smallpox? | Janet Parker, a medical photographer in England |
| Who was the last person to have naturally acquired smallpox? | Ali Maow Maalin, a hospital cook in Somalia |
Explore related products
What You'll Learn
Smallpox vaccination history
Smallpox has been a scourge on humanity for at least 1500 years, and it is estimated that the disease has killed hundreds of millions of people. The virus was transmitted from person to person through inhalation of respiratory droplets or contact with infected material on mucous membranes.
The first method for controlling smallpox was variolation, a process named after the variola virus that causes smallpox. People who had never had smallpox were exposed to material from smallpox sores by scratching the material into their arms or inhaling it through their noses. This method was first employed in North America in 1721 and subsequently spread to Europe.
In 1796, English doctor Edward Jenner noticed that milkmaids who had been infected with cowpox were protected from smallpox. He hypothesized that exposure to cowpox could be used to protect against smallpox. To test his theory, Jenner inoculated James Phipps, the 8-year-old son of his gardener, with material from a cowpox sore. Phipps made a full recovery and was later inoculated with smallpox, to which he showed complete resistance. This was the first successful vaccination against smallpox.
Despite some initial concerns about the safety of the vaccine, it was soon in use all over Europe and the United States. By 1801, through extensive testing, it was shown to effectively protect against smallpox. Mandatory smallpox vaccination came into effect in Britain and parts of the United States in the 1840s and 1850s.
In the 1950s, advances in production techniques allowed for the development of heat-stable, freeze-dried smallpox vaccines that could be stored without refrigeration. This contributed to the success of mass vaccination campaigns. In 1959, the World Health Organization (WHO) began a plan to eradicate smallpox globally, and smallpox was officially declared eradicated by the WHO in 1980.
While the smallpox vaccine was a groundbreaking achievement that saved countless lives, it is important to note that it was not without risks. Some people experienced significant side effects, and in rare cases, the vaccine could even be life-threatening. Today, smallpox infections no longer occur, and the general population is no longer vaccinated against it.
Vaccine Coverage: Does Your Insurance Plan Measure Up?
You may want to see also
Explore related products
Vaccine side effects
The smallpox vaccine was discovered by Dr. Edward Jenner in 1796. He observed that milkmaids who had gotten cowpox were resistant to smallpox. He tested his theory by inoculating James Phipps, the 8-year-old son of his gardener, with matter from a cowpox sore. Phipps made a full recovery and was later inoculated with smallpox, to which he showed complete immunity.
The smallpox vaccine was soon in use on other continents, and mandatory vaccination came into effect in Britain and parts of the United States of America in the 1840s and 1850s. By 1900, smallpox had been eliminated in some European regions, but it continued to ravage colonial territories, causing over 2 million deaths annually.
In the 1950s, advances in production techniques led to the development of heat-stable, freeze-dried smallpox vaccines that could be stored without refrigeration. This, along with the mass production of the bifurcated needle, contributed to the success of the Intensified Eradication Program initiated in 1967. By the time the program began, smallpox had already been eliminated in North America (1952) and Europe (1953).
Despite the success of the smallpox vaccine in eradicating the disease, it is associated with several side effects, ranging from mild to severe and life-threatening. About one-third of first-time vaccine recipients experience significant side effects, such as difficulty sleeping, and 15-20% of children develop fevers exceeding 102 °F (39 °C). The vaccinia lesion can transmit the virus to others, and rare side effects include postvaccinal encephalitis and myopericarditis.
In a 2006 predictive analysis, it was estimated that mass vaccination of the populations of Germany and the Netherlands with the New York City Board of Health strain of the vaccine would result in 9.8 and 46.2 deaths, respectively, from uncontrolled vaccinia infection. The Advisory Committee on Immunization Practices (ACIP) has generally recommended against pre-event smallpox vaccination for the general population due to the risks outweighing the benefits in the absence of confirmed smallpox cases.
Today, smallpox infections no longer occur, and vaccination of the general population has been discontinued. The risks of the smallpox vaccine currently outweigh its benefits. However, if smallpox infections were to re-emerge, the risk-benefit assessment would change significantly.
Amazon's Vaccine Distribution: A Helping Hand?
You may want to see also
Explore related products
Smallpox mortality rate
Smallpox has a recorded history of at least 1500 years, and it is believed to have killed millions of people globally. The disease was transmitted from one person to another primarily through prolonged face-to-face contact or, rarely, via contaminated objects. The overall mortality rate of smallpox is about 30%, with most deaths occurring during the second week of illness. The fatality rate was higher among babies, and survivors often had extensive skin scarring and some were left blind.
The earliest procedure used to prevent smallpox was inoculation with the variola minor virus, which likely occurred in India, Africa, and China before the practice arrived in Europe. This method, later known as variolation after the introduction of the smallpox vaccine, produced lasting immunity to smallpox if successful. However, it could also result in severe infection and the transmission of smallpox to others. Variolation had a 0.5–2% mortality rate, which was considerably lower than the 20–30% mortality rate of smallpox.
In the 18th century, Dr. Edward Jenner of Gloucestershire, England, discovered vaccination and tested his hypothesis by inoculating a boy with cowpox pus and subsequently challenging him with smallpox. The experiment was a success, and Jenner's work soon spread worldwide. The introduction of the vaccine to the New World took place in 1798 by Dr. John Clinch, and the first smallpox vaccine in the United States was administered in 1799 by physician Valentine Seaman. By 1804, an official Spanish mission, the Balmis Expedition, sailed to spread the vaccine throughout the Spanish Empire.
While the smallpox vaccine was highly effective in preventing smallpox infection, it was associated with a range of side effects, from mild to severe and life-threatening. One-third of first-time vaccine recipients experienced significant side effects, and 15–20% of children developed fevers over 102 °F (39 °C). In rare cases, the vaccinia lesion could lead to progressive vaccinia, a condition with a near 100% fatality rate before the development of treatments that reduced the fatality rate to 33%.
The widespread use of variolation and vaccination in the 18th and 19th centuries contributed to a reduction in the impact of smallpox, particularly in wealthy classes and certain regions. By the mid-20th century, improved vaccines, re-vaccination, and mass vaccination campaigns led to a substantial reduction in cases in Europe, North America, and Japan. Universal childhood immunization programs, mass vaccination, and targeted surveillance-containment strategies were key components of the worldwide eradication of smallpox.
Rubella Vaccination: Why Am I Still Susceptible?
You may want to see also
Explore related products
Smallpox vaccine development
Smallpox is a deadly virus that has been a scourge on humanity for at least 1500 years. It is transmitted from person to person and natural infection occurs by inhalation of respiratory droplets or contact with infected material on mucous membranes. It is estimated that about 300 million people died of smallpox in the 20th century, and it killed at least 1 in 3 people infected, often more in its most severe forms.
The first method for controlling smallpox was variolation, where people who had never had smallpox were exposed to material from smallpox sores by scratching it into their arm or inhaling it through their nose. This method was first employed in North America in 1721 and subsequently spread to Boston, where a smallpox epidemic was occurring. Variolation was also used in England, where in 1722 Princess Caroline of Ansbach allowed her children to be variolated.
In the late 18th century, Dr Edward Jenner of Gloucestershire, England, discovered vaccination and the concept of using cowpox to protect against smallpox. Jenner noticed that milkmaids exposed to cowpox appeared to be immune to smallpox. To test his hypothesis, he inoculated an 8-year-old boy, James Phipps, with cowpox pus and then challenged him with smallpox. The experiment was a success, and Jenner went on to test his method on 13 other individuals, as well as himself and his 15-month-old son. In 1798, Dr John Clinch, a friend and colleague of Jenner, introduced the smallpox vaccine to the New World in Trinity, Newfoundland. The first smallpox vaccine in the United States was administered by Valentine Seaman in 1799.
In the 1950s, advances in production techniques meant that heat-stable, freeze-dried smallpox vaccines could be stored without refrigeration. The World Health Organization (WHO) began a plan to rid the world of smallpox in 1959, but this campaign suffered from a lack of funds, personnel, and commitment from countries. The Intensified Eradication Program began in 1967 with renewed efforts, and by this time, smallpox had already been eliminated in North America and Europe.
The last person to die of smallpox was Janet Parker, a medical photographer at Birmingham University Medical School in England, who died on September 11, 1978. Smallpox was declared eradicated by the WHO in 1980, and no cases have occurred since. Due to the eradication of smallpox, the general population is no longer vaccinated against it.
Religious Exemption for Vaccines: Illinois' Legal Requirements
You may want to see also
Explore related products
Smallpox vaccination today
Smallpox vaccination has resurfaced as a topic of major importance due to growing concerns about bioterrorism. Although the last natural case of smallpox was reported in 1977, the threat of its re-emergence, whether through bioterrorism or biological warfare, has led governments to build up vaccine stockpiles. The smallpox vaccine, developed by Edward Jenner in the late 18th century, is the first vaccine created to combat a contagious disease. It is also the oldest vaccine, having gone through several generations of medical technology.
First-generation smallpox vaccines, widely distributed in the 1950s–1970s, were grown on the skin of live animals and can cause serious side effects, including death in a very small number of cases. These vaccines remain viable indefinitely when stored in deep freeze conditions. Second-generation vaccines, grown in cell cultures, offer greater purity and safety, while third-generation vaccines, based on attenuated vaccinia strains, have milder side effects. All three generations of vaccines are available in stockpiles, with second and third-generation vaccines still being produced due to bioterrorism concerns.
In 2007, the US Food and Drug Administration approved ACAM2000, a new live virus vaccine, for use in high-risk individuals. However, due to its adverse effects, its distribution is limited to the CDC's Strategic National Stockpile. The Advisory Committee on Immunization Practices (ACIP) has generally recommended against vaccinating the general population, except for specific groups such as healthcare workers or military personnel.
The success of smallpox vaccination campaigns in the past was due to various strategies, including universal childhood immunization, mass vaccination, and targeted surveillance-containment. International collaboration, particularly between the US and the Soviet Union during the Cold War, was also crucial. The World Health Organization (WHO) played a pivotal role in coordinating technical assistance and vaccine provision, with the Soviet Union supplying freeze-dried vaccines to eliminate smallpox in eastern Europe, China, and India.
Today, the focus is on maintaining vaccine stockpiles and guarding against potential bioterrorism threats. While routine smallpox vaccination is no longer necessary for the general public, the vaccine remains a significant achievement in human history, eradicating a disease that once killed millions indiscriminately.
Vaccination Status: Schools' Right to Ask?
You may want to see also
Frequently asked questions
No, they did not. In fact, the smallpox vaccine was so successful that it eradicated the disease, eliminating it from the face of the earth. The last person to die of smallpox was Janet Parker in 1978.
While the smallpox vaccine was effective, it was associated with several known side effects, ranging from mild and self-limiting to severe and life-threatening. One-third of first-time vaccine recipients experience significant side effects, such as difficulty sleeping, and 15-20% of children develop fevers over 102 °F (39 °C). Rare side effects include postvaccinal encephalitis and myopericarditis.
No, it is not. Smallpox infections no longer occur anywhere in the world, so the general population is no longer vaccinated against it. The risks of the vaccine now outweigh the benefits. However, the U.S. is considering vaccinating selected healthcare workers and the military, and may offer the vaccination to all citizens in the future.
